217 related articles for article (PubMed ID: 24285318)
1. (11) C-labeled and (18) F-labeled PET ligands for subtype-specific imaging of histamine receptors in the brain.
Funke U; Vugts DJ; Janssen B; Spaans A; Kruijer PS; Lammertsma AA; Perk LR; Windhorst AD
J Labelled Comp Radiopharm; 2013; 56(3-4):120-9. PubMed ID: 24285318
[TBL] [Abstract][Full Text] [Related]
2. Radioligands for the dopamine receptor subtypes.
Prante O; Maschauer S; Banerjee A
J Labelled Comp Radiopharm; 2013; 56(3-4):130-48. PubMed ID: 24285319
[TBL] [Abstract][Full Text] [Related]
3. [Molecular imaging of histamine receptors in the human brain].
Tashiro M; Yanai K
Brain Nerve; 2007 Mar; 59(3):221-31. PubMed ID: 17370648
[TBL] [Abstract][Full Text] [Related]
4. Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.
Bao X; Lu S; Liow JS; Zoghbi SS; Jenko KJ; Clark DT; Gladding RL; Innis RB; Pike VW
J Med Chem; 2012 Mar; 55(5):2406-15. PubMed ID: 22313227
[TBL] [Abstract][Full Text] [Related]
5. PET radioligands targeting the brain GABAA /benzodiazepine receptor complex.
Andersson JD; Halldin C
J Labelled Comp Radiopharm; 2013; 56(3-4):196-206. PubMed ID: 24285326
[TBL] [Abstract][Full Text] [Related]
6. The physiological and pathophysiological roles of neuronal histamine: an insight from human positron emission tomography studies.
Yanai K; Tashiro M
Pharmacol Ther; 2007 Jan; 113(1):1-15. PubMed ID: 16890992
[TBL] [Abstract][Full Text] [Related]
7. (11)C-MK-8278 PET as a tool for pharmacodynamic brain occupancy of histamine 3 receptor inverse agonists.
Van Laere KJ; Sanabria-Bohórquez SM; Mozley DP; Burns DH; Hamill TG; Van Hecken A; De Lepeleire I; Koole M; Bormans G; de Hoon J; Depré M; Cerchio K; Plalcza J; Han L; Renger J; Hargreaves RJ; Iannone R
J Nucl Med; 2014 Jan; 55(1):65-72. PubMed ID: 24263088
[TBL] [Abstract][Full Text] [Related]
8. Current status of positron emission tomography radiotracers for serotonin receptors in humans.
Zimmer L; Le Bars D
J Labelled Comp Radiopharm; 2013; 56(3-4):105-13. PubMed ID: 24285316
[TBL] [Abstract][Full Text] [Related]
9. Inverse agonist histamine H3 receptor PET tracers labelled with carbon-11 or fluorine-18.
Hamill TG; Sato N; Jitsuoka M; Tokita S; Sanabria S; Eng W; Ryan C; Krause S; Takenaga N; Patel S; Zeng Z; Williams D; Sur C; Hargreaves R; Burns HD
Synapse; 2009 Dec; 63(12):1122-32. PubMed ID: 19670309
[TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis and biodistribution of a histamine H3 receptor antagonist 4-[3-(4-piperidin-1-yl-but-1-ynyl)-[11C]benzyl]-morpholine: evaluation of a potential PET ligand.
Airaksinen AJ; Jablonowski JA; van der Mey M; Barbier AJ; Klok RP; Verbeek J; Schuit R; Herscheid JD; Leysen JE; Carruthers NI; Lammertsma AA; Windhorst AD
Nucl Med Biol; 2006 Aug; 33(6):801-10. PubMed ID: 16934699
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
[TBL] [Abstract][Full Text] [Related]
12. Histamine in migraine and brain.
Alstadhaug KB
Headache; 2014 Feb; 54(2):246-59. PubMed ID: 24433203
[TBL] [Abstract][Full Text] [Related]
13. 11C-GSK189254: a selective radioligand for in vivo central nervous system imaging of histamine H3 receptors by PET.
Plisson C; Gunn RN; Cunningham VJ; Bender D; Salinas CA; Medhurst AD; Roberts JC; Laruelle M; Gee AD
J Nucl Med; 2009 Dec; 50(12):2064-72. PubMed ID: 19910432
[TBL] [Abstract][Full Text] [Related]
14. Radiofluorinated histamine H₃ receptor antagonist as a potential probe for in vivo PET imaging: radiosynthesis and pharmacological evaluation.
Selivanova SV; Honer M; Combe F; Isensee K; Stark H; Krämer SD; Schubiger PA; Ametamey SM
Bioorg Med Chem; 2012 May; 20(9):2889-96. PubMed ID: 22483590
[TBL] [Abstract][Full Text] [Related]
15. The potential of carbon-11 and fluorine-18 chemistry: illustration through the development of positron emission tomography radioligands targeting the translocator protein 18 kDa.
Damont A; Roeda D; Dollé F
J Labelled Comp Radiopharm; 2013; 56(3-4):96-104. PubMed ID: 24285315
[TBL] [Abstract][Full Text] [Related]
16. Radiosynthesis of carbon-11 and fluorine-18 labelled radiotracers to image the ionotropic and metabotropic glutamate receptors.
Sobrio F
J Labelled Comp Radiopharm; 2013; 56(3-4):180-6. PubMed ID: 24285324
[TBL] [Abstract][Full Text] [Related]
17. The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET).
Banister SD; Manoli M; Kassiou M
J Labelled Comp Radiopharm; 2013; 56(3-4):215-24. PubMed ID: 24285328
[TBL] [Abstract][Full Text] [Related]
18. New findings in pharmacological effects induced by antihistamines: from PET studies to knock-out mice.
Yanai K; Okamura N; Tagawa M; Itoh M; Watanabe T
Clin Exp Allergy; 1999 Jul; 29 Suppl 3():29-36; discussion 37-8. PubMed ID: 10444209
[TBL] [Abstract][Full Text] [Related]
19. Synthetic strategies for radioligands for in vivo imaging of brain cannabinoid type-1 receptors.
Ahamed M; Verbruggen A; Bormans G
J Labelled Comp Radiopharm; 2013; 56(3-4):207-14. PubMed ID: 24285327
[TBL] [Abstract][Full Text] [Related]
20. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.
Tashiro M; Mochizuki H; Sakurada Y; Ishii K; Oda K; Kimura Y; Sasaki T; Ishiwata K; Yanai K
Br J Clin Pharmacol; 2006 Jan; 61(1):16-26. PubMed ID: 16390347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
